IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ROMANI, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.240
EU - Europa 2.015
AS - Asia 1.744
SA - Sud America 284
AF - Africa 31
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 8.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.157
PL - Polonia 613
SG - Singapore 596
CN - Cina 563
IT - Italia 343
DE - Germania 260
BR - Brasile 249
UA - Ucraina 245
HK - Hong Kong 214
FI - Finlandia 144
VN - Vietnam 105
GB - Regno Unito 96
TR - Turchia 71
IE - Irlanda 62
RU - Federazione Russa 61
CA - Canada 53
FR - Francia 43
IN - India 41
BD - Bangladesh 33
NL - Olanda 28
SE - Svezia 28
ID - Indonesia 27
EE - Estonia 23
MX - Messico 22
AR - Argentina 21
ZA - Sudafrica 18
JP - Giappone 16
ES - Italia 14
CZ - Repubblica Ceca 11
IQ - Iraq 11
AT - Austria 10
LT - Lituania 9
BE - Belgio 8
KG - Kirghizistan 8
BG - Bulgaria 6
PK - Pakistan 6
AU - Australia 5
KR - Corea 5
LK - Sri Lanka 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CO - Colombia 4
NI - Nicaragua 4
NP - Nepal 4
TW - Taiwan 4
EC - Ecuador 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
PH - Filippine 3
PT - Portogallo 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
DZ - Algeria 2
KE - Kenya 2
LU - Lussemburgo 2
MA - Marocco 2
MY - Malesia 2
OM - Oman 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CL - Cile 1
GD - Grenada 1
IR - Iran 1
LV - Lettonia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 8.324
Salva come PNG Salva come JPEG
Città #
Warsaw 609
Fairfield 466
Ashburn 417
Woodbridge 328
Singapore 303
Houston 280
Chandler 241
Seattle 218
Hong Kong 193
Jacksonville 175
New York 173
Wilmington 165
Cambridge 143
Ann Arbor 128
Beijing 122
Los Angeles 114
Dearborn 106
Princeton 101
Helsinki 89
Brescia 83
Nanjing 63
Dublin 62
Munich 59
Istanbul 56
Dallas 47
Shanghai 45
Dong Ket 44
Milan 43
The Dalles 43
São Paulo 32
Des Moines 31
Buffalo 30
Chicago 30
Moscow 29
San Francisco 29
London 26
Toronto 25
Jakarta 23
Tallinn 23
San Diego 21
Denver 20
Redondo Beach 20
Shenyang 20
Jinan 19
Tianjin 19
Turku 19
Hanoi 18
Ho Chi Minh City 18
Nanchang 18
Montreal 17
Johannesburg 16
Brooklyn 15
Kunming 15
Phoenix 15
Santa Clara 15
Central 14
Changsha 14
Hangzhou 14
Tokyo 14
Chennai 13
Hebei 13
Nuremberg 13
Jiaxing 12
Guangzhou 11
Poplar 11
Rome 11
Stockholm 11
Boston 10
Charlotte 10
Monmouth Junction 10
Zhengzhou 10
Atlanta 9
Mexico City 9
Paris 9
Ankara 8
Belo Horizonte 8
Bishkek 8
Lappeenranta 8
Brussels 7
Falkenstein 7
Leawood 7
Manchester 7
Mumbai 7
Norwalk 7
Orem 7
Verona 7
Amsterdam 6
Boardman 6
Miami 6
Pune 6
Rio de Janeiro 6
Brno 5
Council Bluffs 5
Curitiba 5
Hefei 5
Kilburn 5
Kyiv 5
Ningbo 5
Olomouc 5
Querétaro 5
Totale 5.860
Salva come PNG Salva come JPEG
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 326
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 311
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 309
Claudin3 is localized outside the tight junctions in human carcinomas 272
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 264
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 202
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 191
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 189
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 187
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 185
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 183
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 180
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 174
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 172
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 170
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 166
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 166
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 164
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 162
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 161
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 157
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 151
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. 151
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 151
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 149
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 140
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 139
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 134
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 131
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 128
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 123
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 122
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 121
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 116
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 113
Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R. 111
Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response. 107
OVEREXPRESSION OF EPIDERMAL GROWTH FACTOR TYPE-1 RECEPTOR (EGF-R1) IN CERVICAL CANCER: IMPLICATIONS FOR CETUXIMAB-MEDIATED THERAPY IN RECURRENT/METASTATIC DISEASE. 104
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 99
Stability of circulating miRNA in saliva: The influence of sample associated pre-analytical variables 98
Human papillomavirus type 16 (HPV-16) virus-like particleL1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. 96
Integrated mutational landscape analysis of uterine leiomyosarcomas 95
HE4 and epithelial ovarian cancer : Comparison and clinical evaluation of two immunoassays and a combination algorithm 95
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 92
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 90
Trop-2 Overexpression in Poorly Differentiated Endometrial Endometrioid Carcinoma: Implications for Immunotherapy With hRS7, a Humanized Anti-Trop-2 Monoclonal Antibody 88
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 88
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 87
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 84
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 84
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 83
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 80
Uso di miRNA come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose 77
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer 69
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 62
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 61
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 56
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 55
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 54
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies 53
Finding the junction between claudins and endometrial carcinoma 46
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients 45
The VEGF/VEGFR2 system in ovarian cancer: From functional to pharmacological significance 40
HPV16VLP L1-Specific CD8+ cytotoxic T lymphocytes (CTL) are equally effective as E7-specific CD8+ CTL in killing autologous HPV16 positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines 37
The prognostic role of salivary miRNAs in oral squamous cell carcinoma: technical challenges and clinical perspectives 36
Mammaglobin B (SCGB2A1) is a novel tumor antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy 34
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders 15
Totale 8.481
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021632 0 0 0 0 0 85 53 103 98 135 86 72
2021/2022544 64 92 11 3 5 32 48 28 26 97 38 100
2022/2023611 90 38 32 40 60 126 8 66 84 6 35 26
2023/2024775 38 25 78 56 43 189 45 45 124 44 15 73
2024/20251.425 28 41 29 246 112 148 109 51 137 94 265 165
2025/20261.695 310 273 213 472 391 36 0 0 0 0 0 0
Totale 8.481